Maximus registered a growth of 32% in Revenue and Net Profit in FY’22

Mumbai (Maharashtra) [India], June 11: Consolidating its business and managing margins effectively during covid times has enabled one of the leading manufacturers of finest lubricants in East Africa and Middle East, Maximus International Limited (MIL) to achieve Total Revenue of Rs. 70.42 Crore on a consolidated basis for the year ended March 31, 2022 (FY 22) as against Rs. 53.12 Crore for the previous year ended March 31, 2021 (FY 21), registering a growth of 32.6%. It has clocked a Net Profit of Rs. 4.66 Crore on a consolidated basis in FY 22 which is 32% higher than the consolidated Net Profit of Rs. 3.53 Crore for FY 21.

MIL is happy to note its strategies to effectively manage business, margins, competition etc has stood it in good stead.  Every vulnerable situation, be it supply chain disruption, competitiveness in pricing, or lower demand in the market etc have been dealt with by prudent and diligent strategies aided by immaculate execution of these by its teams in India, UAE & Kenya. “Such uncertainties/challenges faced have been turned into opportunities that led to efficient Macro/Micromanaging of Supply chain, robust and practical Credit Management & deeper customer/distributor engagement. We have a long-term vision of growing our company globally—our African foray is in line with this strategy. As the after-effects of Covid-19 wear off, we are well prepared to grow exponentially over the next few years,” said Mr Deepak Raval, Managing Director, Maximus International Limited.

“The company now plans to consolidate its operations and foray into new markets in both Asia and Africa. The company is confident that it can sustain the continuous growth that it has been maintaining for the last 5 years by expanding its footprint in the African continent.,” said Mr Milind Joshi, Chief Financial Officer (CFO), Maximus International Limited.

With its manufacturing facilities as well as strong market presence in UAE and Kenya, they cater to more than 400 customers spread over 25 countries.

MIL is confident that it can sustain the continuous growth that they have been maintaining for the last 5 years by expanding its footprint in the African continent.

If you have any objection to this press release content, kindly contact to notify us. We will respond and rectify the situation in the next 24 hours.

Leave a Reply

Your email address will not be published.


Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 15.01 crore in Q1FY23

Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd Business Highlights:- Total Income in Q1FY23 at Rs. 129.97 crore, up 24.4% from Rs. 104.4 crore in Q4FY22 Commercial operations of Cephalosporin Plant and Export to EU & Australia to commence in FY23 Company continuous to remain ‘Net Debt Free’ after multiple expansion & acquisition of Cephalosporin plant […]